Detailansicht

Wissensnetz

Person

Sven Mahner (1975-)

Gynäkologe

Name	Sven Mahner
Zeit	1975- (Lebensdaten)
Ort	Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Priv.-Doz. Dr. med.
Beruf	Gynäkologe (charakteristischer Beruf) Arzt
Beziehung	Universitätsklinikum Hamburg-Eppendorf
Weitere Angaben	Diss. Medizinische Fakultät, Innere Medizin IV Universitätsklinik Heidelberg Univ. Hamburg, Medizinische Fak., Universitätsklinikum Hamburg-Eppendorf, Zentrum für Operative Medizin, Klinik und Poliklinik für Gynäkologie, Oberarzt und Koordinator des Gynäkologischen Krebszentrums
Quelle	http://www.uke.de/kliniken/frauenklinik/images_content/klinik-gynaekologie/Lebenslauf_PD_Mahner_April_2012.pdf
Datensatztyp	Person
GND-Nummer	130244775
Datensatz-ID	130244775
Beteiligt an alle anzeigen Genetic variants of interleukin-8 and interleukin-16 and their association with cervical cancer risk Association of four interleukin-8 polymorphisms (−251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with ovarian cancer risk: focus on menopausal status and endometriosis-related subtypes Association of the single nucleotide polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the interleukin-16 gene with ovarian cancer Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ) Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study T-cell density at the invasive margin and immune phenotypes predict outcome in vulvar squamous cell cancer The role of E-Cadherin expression in primary site of breast cancer Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus Familiärer Brust- und Eierstockkrebs: Auf was achten, was tun? Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study Late Presentation at Primary Diagnosis of Breast Cancer: Patients’ Personality Characteristics and Attitudes Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer G protein-coupled estrogen receptor correlates with Dkk2 expression and has prognostic impact in ovarian cancer patients Role of pelvic lymph node resection in vulvar squamous cell cancer: a subset analysis of the ago-care-1 study Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study The role of E-Cadherin expression in primary site of breast cancer NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers Management des Mammakarzinoms beim Mann Pelvic Lymphadenectomy in Vulvar Cancer – Does it make sense? Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer? EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients Cytoplasmic and nuclear forms of thyroid hormone receptor β1 are inversely associated with survival in primary breast cancer Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer Moderne Möglichkeiten der onkoplastischen Brustchirurgie Mammakarzinom bei jungen Frauen: Was Sie wissen sollten Brustkrebs-Patientinnen brauchen auch Ihre Unterstützung! Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium Factors associated with the decline of psychological support in hospitalized patients with cancer Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report The prognostic impact of the Aryl Hydrocarbon Receptor (AhR) in primary breast cancer depends on the lymph node status Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration Tastbefund an der Brust: Auch bei Männern immer abklären! Participation of elderly gynecological cancer patients in clinical trials TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer Tastbefund an der Brust: Auch bei Männern immer abklären! Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases Tastbefund an der Brust: Auch bei Männern immer abklären! Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study Evaluation of reproductive concerns and biographical impact of breast cancer in young patients Tastbefund an der Brust: Auch bei Männern immer abklären! Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling Blasenschwäche: Was Sie als Hausarzt wissen sollten Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Sven Mahner (1975-)

Genetic variants of interleukin-8 and interleukin-16 and their association with cervical cancer risk

Association of four interleukin-8 polymorphisms (−251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with ovarian cancer risk: focus on menopausal status and endometriosis-related subtypes

Association of the single nucleotide polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the interleukin-16 gene with ovarian cancer

Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ)

Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany

Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany

Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report

Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics

Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study

T-cell density at the invasive margin and immune phenotypes predict outcome in vulvar squamous cell cancer

The role of E-Cadherin expression in primary site of breast cancer

Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany

Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer

Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus

Familiärer Brust- und Eierstockkrebs: Auf was achten, was tun?

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer

Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study

Late Presentation at Primary Diagnosis of Breast Cancer: Patients’ Personality Characteristics and Attitudes

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer

G protein-coupled estrogen receptor correlates with Dkk2 expression and has prognostic impact in ovarian cancer patients

Role of pelvic lymph node resection in vulvar squamous cell cancer: a subset analysis of the ago-care-1 study

Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study

The role of E-Cadherin expression in primary site of breast cancer

NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU

Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers

Management des Mammakarzinoms beim Mann

Pelvic Lymphadenectomy in Vulvar Cancer – Does it make sense?

Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?

EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients

Cytoplasmic and nuclear forms of thyroid hormone receptor β1 are inversely associated with survival in primary breast cancer

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer

Moderne Möglichkeiten der onkoplastischen Brustchirurgie

Mammakarzinom bei jungen Frauen: Was Sie wissen sollten

Brustkrebs-Patientinnen brauchen auch Ihre Unterstützung!

Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium

Factors associated with the decline of psychological support in hospitalized patients with cancer

Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report

The prognostic impact of the Aryl Hydrocarbon Receptor (AhR) in primary breast cancer depends on the lymph node status

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration

Tastbefund an der Brust: Auch bei Männern immer abklären!

Participation of elderly gynecological cancer patients in clinical trials

TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer

Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

Tastbefund an der Brust: Auch bei Männern immer abklären!

Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases

Tastbefund an der Brust: Auch bei Männern immer abklären!

Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology

Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients

Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages

Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

Evaluation of reproductive concerns and biographical impact of breast cancer in young patients

Tastbefund an der Brust: Auch bei Männern immer abklären!

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling

Blasenschwäche: Was Sie als Hausarzt wissen sollten

Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer

Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients